References
- Braaten, K. P. & Laufer, M. R. Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev Obstet Gynecol 1, 2-10 (2008).
- Molijn, A., Kleter, B., Quint, W. & van Doorn, L. J. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32 Suppl 1, S43-51, doi:10.1016/j.jcv.2004.12.004 (2005).
- Vance, J. C. et al. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 122, 272-277 (1986). https://doi.org/10.1001/archderm.1986.01660150050014
- Hursthouse, M. W. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol 92, 93-96, doi:10.1111/j.1365-2133.1975.tb03039.x (1975).
- Sterling, J., Handfield-Jones, S. & Hudson, P. J. B. J. o. D. Guidelines for the management of cutaneous warts. 144, 4-11 (2001). https://doi.org/10.1046/j.1365-2133.2001.04066.x
- Aragona, C., Bezerra Espinola, M. S., Bilotta, G., Porcaro, G. & Calcagno, M. J. J. o. C. M. Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study. 12, 2171 (2023).
- Steinberg, M. D. A new treatment for resistant warts; report of 300 cases. Surgery 39, 642-644 (1956).
- Giuliano, A. R. et al. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 6, 917-923 (1997).
- Forbes, M. A. & Schmid, M. M. Use of OTC essential oils to clear plantar warts. Nurse Pract 31, 53-55, 57, doi:10.1097/00006205-200603000-00019 (2006).